The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The INRange RCT
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 217 participants.
Also called NCT02376803
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 217 participants
- Sponsor
- Registry
-
NCT02376803
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02376803. Randomized; no masking; primary purpose treatment. Start 2015-02 (registry gives no type); primary completion 2016-09-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
- Condition
- Atrial Fibrillation
- Condition
- Thrombus Due to Heart Valve Prosthesis
- Condition
- Deep Venous Thrombosis
- Condition
- Thromboembolism
- Condition
- DVT (deep vein thrombosis)
- Intervention (Drug)
- Warfarin
- Lead sponsor
- University of Alberta
- Collaborator
- Vancouver Coastal Health Research Institute
Record details
- Record id
cardio:ct-nct02376803- Content hash
25277468ab9888e7eb2f7e17eb487eaac852de121de739df77dacafa290266b6